Nihon Chouzai Co Ltd
TSE:3341
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Qingdao Foods Co Ltd
SZSE:001219
|
CN |
|
Z
|
Zhejiang Zhengte Co Ltd
SZSE:001238
|
CN |
EV/EBITDA
Enterprise Value to EBITDA (EV/EBITDA) ratio compares a company`s total enterprise value to its earnings before interest, taxes, depreciation, and amortization. It shows how much investors are paying for each dollar of the company`s earnings, including both equity and debt.
Enterprise Value to EBITDA (EV/EBITDA) ratio compares a company`s total enterprise value to its earnings before interest, taxes, depreciation, and amortization. It shows how much investors are paying for each dollar of the company`s earnings, including both equity and debt.
Valuation Scenarios
If EV/EBITDA returns to its 3-Year Average (1.4), the stock would be worth ¥180 405.43 (82% downside from current price).
| Scenario | EV/EBITDA Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | 7.9 | ¥1 000 000 |
0%
|
| 3-Year Average | 1.4 | ¥180 405.43 |
-82%
|
| 5-Year Average | 1.4 | ¥175 252.69 |
-82%
|
| Industry Average | 7.9 | ¥1 000 000 |
0%
|
| Country Average | 8.7 | ¥1 092 917.21 |
+9%
|
Forward EV/EBITDA
Today’s price vs future ebitda
| Today's Enterprise Value | EBITDA | Forward EV/EBITDA | ||
|---|---|---|---|---|
|
¥154.3B
|
/ |
Oct 2025
¥19.5B
|
= |
|
|
¥154.3B
|
/ |
Mar 2026
¥17.7B
|
= |
|
|
¥154.3B
|
/ |
Mar 2027
¥19B
|
= |
|
|
¥154.3B
|
/ |
Mar 2028
¥19.2B
|
= |
|
Forward EV/EBITDA shows whether today’s EV/EBITDA still looks high or low once future ebitda are taken into account.
Peer Comparison
| Market Cap | EV/EBITDA | P/E | ||||
|---|---|---|---|---|---|---|
| JP |
|
Nihon Chouzai Co Ltd
TSE:3341
|
113.8B JPY | 7.9 | 44.8 | |
| ZA |
C
|
Clicks Group Ltd
JSE:CLS
|
71B ZAR | 10.7 | 21.9 | |
| ZA |
D
|
Dis-Chem Pharmacies Ltd
JSE:DCP
|
32B ZAR | 16.3 | 25.9 | |
| US |
|
Walgreens Boots Alliance Inc
NASDAQ:WBA
|
10.4B USD | 3 | -1.6 | |
| BR |
|
Raia Drogasil SA
BOVESPA:RADL3
|
40.8B BRL | 9.8 | 30.6 | |
| JP |
|
Tsuruha Holdings Inc
TSE:3391
|
933.4B JPY | 9.5 | 21.9 | |
| JP |
|
MatsukiyoCocokara & Co
TSE:3088
|
929.6B JPY | 7.7 | 16.6 | |
| SA |
|
Al Nahdi Medical Company SCJSC
SAU:4164
|
16.8B SAR | 10.2 | 20.2 | |
| CN |
|
Yifeng Pharmacy Chain Co Ltd
SSE:603939
|
28.4B CNY | 10.1 | 17.3 | |
| JP |
|
Welcia Holdings Co Ltd
TSE:3141
|
657.7B JPY | 9.1 | 34.3 | |
| JP |
S
|
Sugi Holdings Co Ltd
TSE:7649
|
612.8B JPY | 8.6 | 13.6 |
Market Distribution
| Min | 0.1 |
| 30th Percentile | 6.7 |
| Median | 8.7 |
| 70th Percentile | 12.2 |
| Max | 214 699 781.2 |
Other Multiples
Nihon Chouzai Co Ltd
Glance View
NIHON CHOUZAI Co., Ltd. engages in the business of pharmaceutical industry. The company is headquartered in Chiyoda-Ku, Tokyo-To and currently employs 5,221 full-time employees. The company went IPO on 2004-09-17. The firm operates in three business segments. The Pharmacy segment is engaged in the operation of a chain of dispensing pharmacies. The Pharmaceutical Product Manufacturing and Distribution segment is engaged in the manufacture and nationwide sale of generic pharmaceutical products. The Healthcare Personnel Staffing Service segment is involved in the dispatching of pharmacists to various regional pharmacies.
